Antitussive action of nociceptin in the cat

Eur J Pharmacol. 2001 Oct 26;430(1):107-11. doi: 10.1016/s0014-2999(01)01244-4.


Experiments were conducted to determine the influence of the specific ORL1 receptor agonist, nociceptin, on the cough reflex in the cat. Cats were anesthetized and allowed to breathe spontaneously. Cough was elicited by mechanical stimulation of the intrathoracic airway. Intravenous administration of nociceptin (0.001-3.0 mg x kg(-1)) inhibited cough number and the magnitude of abdominal muscle electromyogram (EMG) discharge during cough in a dose-dependent manner. Nociceptin had no effect on the magnitude of the inspiratory muscle EMG during cough. These effects of nociceptin were antagonized by pretreatment with the ORL1 receptor antagonist, 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397, 0.1 mg x kg(-1), i.v.). We conclude that intravenous nociceptin inhibits cough in the cat.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Muscles / drug effects
  • Abdominal Muscles / physiopathology
  • Animals
  • Antitussive Agents / pharmacology*
  • Antitussive Agents / therapeutic use
  • Benzimidazoles / pharmacology
  • Cats
  • Cough / drug therapy*
  • Cough / etiology
  • Cough / physiopathology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Electromyography
  • Injections, Intravenous
  • Opioid Peptides / antagonists & inhibitors
  • Opioid Peptides / pharmacology*
  • Opioid Peptides / therapeutic use
  • Piperidines / pharmacology


  • Antitussive Agents
  • Benzimidazoles
  • J 113397
  • Opioid Peptides
  • Piperidines
  • nociceptin